Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELIRI-A in Untreated Metastatic Colorectal Cancer
NCT00483834Phase 2Completed
- Sponsor
- University Health Network
- Start
- Dec 2006
- Primary completion
- Jul 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (metastatic) (mCRC), sponsored by University Health Network. Started Dec 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00483834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483834.